🦊/Companies

RebrAIn

Bordeaux, FR · Founded 2021 · 24 employees on LinkedIn · 1 known investors

Find your way into RebrAIn

252 people in our graph share verified history with the RebrAIn team — schools, employers, funds. One of them is your warm intro.

Michèle Ollierunlockedknows Emmanuel Cuny · together at Université Paris Descartes (overlapped)
×4knows the team · via Université Paris Cité
×6knows the team · via Télécom Paris
knows the team · via Université Paris Descartes

Rebrain provides an AI-driven SaaS platform for planning patient-specific neuromodulation and neurosurgery, aiming to make treatment of neurological and neurodegenerative diseases faster and safer for doctors and patients. It is a spin-off of the University Hospital of Bordeaux and Inria, serving medical centers and neurosurgeons.

Founders & leadership

RebrAIn was founded in 2021 by Emmanuel Cuny and Nejib Zemzemi.

ECEmmanuel Cuny
Emmanuel CunyinCo-founder, CMO & Board PresidentFunctional neurosurgeon with clinical practice since the early 1990s focused on movement disorders and pain, and researcher at INRIA who spent 10 years developing a surgical targeting model with Nejib Zemzemi. Co-founder and Chief Medical Officer of RebrAIn, a spin-off platform for AI-driven neuromodulation planning that has supported over 1,000 brain targeting procedures across European and U.S. centers.
NZNejib Zemzemi
Nejib ZemzemiCo-founder, CSO & CTO
DCDavid Caumartin
David CaumartininCEODavid Caumartin spent 15 years at GE Healthcare in medical imaging, including management of a $350M global business, before serving as CEO of Theraclion, a Euronext-listed company that developed focused ultrasound technology and treated thousands of patients. He is now CEO of RebrAIn, an FDA-cleared neurosurgery planning software company based in Bordeaux.

Investors · 1

In the news

Frequently asked questions

What does RebrAIn do?
Rebrain provides an AI-driven SaaS platform for planning patient-specific neuromodulation and neurosurgery, aiming to make treatment of neurological and neurodegenerative diseases faster and safer for doctors and patients. It is a spin-off of the University Hospital of Bordeaux and Inria, serving medical centers and neurosurgeons.
Who founded RebrAIn?
RebrAIn was founded by Emmanuel Cuny, Nejib Zemzemi in 2021.
Who are RebrAIn's investors?
RebrAIn's investors include Karista.
Where is RebrAIn headquartered?
RebrAIn is headquartered in Bordeaux, FR.